SYNOPSISInvestigation of the interplay between the cerebral circulation and brain cellular function is fundamental to understanding both the pathophysiology and treatment of stroke. Currently, PET is the only technique that provides accurate, quantitative in vivo regional measurements of both cerebral circulation and cellular metabolism in human subjects. We review normal human cerebral blood flow and metabolism and human PET studies of ischemic stroke, carotid artery disease, vascular dementia, intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage and discuss how these studies have added to our understanding of the pathophysiology of human cerebrovascular disease.
Keywordspositron emission tomography; cerebrovascular disease; vascular dementia; cerebral blood flow; cerebral metabolism; cerebral hemodynamics
INTRODUCTIONCerebrovascular disease results from a derangement of the normal relationship between the cerebral vasculature and the brain parenchyma. Thus, investigation of the interplay between the cerebral circulation and brain cellular function is fundamental to understanding both the pathophysiology and treatment of stroke. Currently, PET is the only technique that provides accurate, quantitative in vivo regional measurements of both cerebral circulation and cellular metabolism in human subjects. It is therefore well-suited for the study of human cerebrovascular disease, but its application to this end is not easy. An on-site cyclotron and radiochemistry facility is necessary due to the short half-lives of the commonly used radionuclides 15 O (2 minutes) and 11 C (20 minutes). Quantitative physiological measurements require complex postprocessing and multiple arterial blood samples, although for some specific applications simple count-based images can be used.(1;2) Patients with acute stroke may be medically unstable, requiring a nurse or physician in attendance. For these reasons, PET is still a research tool for cerebrovascular disease. It has provided us with valuable new knowledge and insight into both ischemic and hemorrhagic stroke regarding pathophysiology, therapy and Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public AccessAuthor Manuscript PET Clin. Author manuscript; available in PMC 2011 January 1.
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript prognosis but has not entered the mainstream of clinical practice. In the future, the results of the Carotid Occlusion Surgery Study (www.cosstrial.org), an ongoing clinical trial in which PET is being used to determine eligibility, may demonstrate the clinical value ...